SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

2 results loaded, newest first. End of these results.

News 2026-10-14 10:05 UTC

Verastem appoints Michael P. Bailey CEO effective Jan. 1, 2027

Verastem named Michael P. Bailey president and CEO, effective Jan. 1, 2027, succeeding Daniel Paterson, who will retire. Bailey has served on Verastem’s board since May 2026; he previously ran AVEO Pharmaceuticals as president and CEO from 2015. Paterson will remain an advisor and continue as a board member. Disclaimer